Federal contract award

75A50124C00010

DEVELOPMENT OF A NOVEL PRALIDOXIME CHLORIDE AUTO-INJECTOR DEVICE

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeBARDA - ASPR / DAAPPO / BARDA DCMA
NAICS541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSCAN42 — HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeCOST PLUS FIXED FEE
Obligations$33.3M
Current contract value$33.3M
Potential contract value / ceiling$33.8M
Start dateApr 11, 2024
Current end dateOct 31, 2028
Potential end dateOct 31, 2028
Latest award activityMar 16, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Mar 16, 2026P00003$3.8MDEVELOPMENT OF A NOVEL PRALIDOXIME CHLORIDE AUTO-INJECTOR DEVICE
Dec 20, 2024P00002$26.0MDEVELOPMENT OF A NOVEL PRALIDOXIME CHLORIDE AUTO-INJECTOR DEVICE
Sep 5, 2024P00001$0DEVELOPMENT OF A NOVEL PRALIDOXIME CHLORIDE AUTO-INJECTOR DEVICE
Apr 11, 20240$3.5MDEVELOPMENT OF A NOVEL PRALIDOXIME CHLORIDE AUTO-INJECTOR DEVICE

Estimated positioning window

Oct 31, 2027 – Apr 30, 2028

Recompete signal:
70/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 70/100. Available recorded signals: 65 points.

Contract end 2028-10-31 (730 days from calculation)
+25 points
22 historical awards in this buyer and category group
+15 points
4 recorded award transactions
+10 points
Latest award action: 2026-03-16
+5 points
Parent award identifier recorded
+0 points
Solicitation identifier recorded
+10 points
Linked official forecast
+0 points
Calculated on
2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
BARDA-BAA@hhs.govContactBARDA-BAA@hhs.govSourceMar 20, 2026
BARDA-BAA@hhs.govContactBARDA-BAA@hhs.govSourceMar 19, 2026
BARDA-BAA@hhs.govContactBARDA-BAA@hhs.govSourceMay 29, 2025
BARDA-BAA@hhs.govContactBARDA-BAA@hhs.govSourceDec 18, 2024
BARDA-BAA@hhs.govContactBARDA-BAA@hhs.govSourceMay 31, 2024
BARDA-BAA@hhs.govContactBARDA-BAA@hhs.govSourceApr 23, 2024
BARDA-BAA@hhs.govContactBARDA-BAA@hhs.govSourceMar 29, 2024
BARDA-BAA@hhs.govContactBARDA-BAA@hhs.govSourceDec 22, 2023
BARDA-BAA@hhs.govContactBARDA-BAA@hhs.govSourceNov 9, 2023
BARDA-BAA@hhs.govContactBARDA-BAA@hhs.govSourceSep 26, 2023

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Check the stated set-aside against the solicitation and current certifications.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.